What are the possible side effects of using serputinib/serpatinib?

Selpercatinib as a RET targeted inhibitor, provides treatment for non-small cell lung cancer ( NSCLC) . Thyroid cancer treatment may also cause certain side effects. Common adverse reactions mainly include digestive system symptoms, such as diarrhea, nausea, vomiting and loss of appetite. Most of these reactions are mild to moderate and can be alleviated through dietary adjustments or symptomatic drug management. Some patients may experience liver function abnormalities, such as elevated transaminases, so liver function indicators need to be monitored regularly during treatment to facilitate timely intervention.

Hypertension is also a side effect that requires attention when using seputinib, which is mainly related to the drug's effect on blood vessel-related signaling pathways. Patients should have their blood pressure measured regularly during treatment and, if necessary, combined with antihypertensive drug management. Dry skin, fatigue, and mild fatigue are also common manifestations in clinical observations, and these can usually be alleviated by adjusting lifestyle or drug dosage.

Rare but serious adverse events that require attention include QT interval prolongation and interstitial pneumonia. The incidence is relatively low, but they require immediate treatment once they occur. Clinically, doctors will make individual adjustments to the dose according to the patient's tolerance, including temporarily stopping the drug or reducing the dose, to balance efficacy and safety. For patients taking long-term medication, regular follow-up and monitoring are the key to ensuring efficacy and reducing risks.

In general, the adverse reactions of seputinib are generally controllable, and its safety has been verified in clinical practice. ForRET-positive patients, the benefits brought by precise targeted therapy usually far outweigh the potential risks. Through scientific management and individualized adjustment, both drug safety and efficacy can be guaranteed. This also reflects the concept of modern targeted therapy to achieve medical treatment and safety management in oncology.

Reference:https://en.wikipedia.org/wiki/Selpercatinib